cell lines sh sy5y wt atcc cat (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
cell lines sh sy5y wt atcc cat
Cell Lines Sh Sy5y Wt Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9310 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+sh+sy5y+wt+atcc+cat/SH-SY5Y/pm37972592-300-103-107
Average 99 stars, based on 9310 article reviews
Cell Lines Sh Sy5y Wt Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9310 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+sh+sy5y+wt+atcc+cat/SH-SY5Y/pm37972592-300-103-107
Average 99 stars, based on 9310 article reviews
cell lines sh sy5y wt atcc cat - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
SYBR Green Assay:Article Title: A bidirectional link between sulfatide and Alzheimer's disease. Article Snippet: In brief Zimmer et al. report that the glycosphingolipid sulfatide is reduced in brains of Alzheimer’s patients.. AICD inhibits CST expression, necessary for sulfatide synthesis.. In return, sulfatides inhibit amyloidogenic APP processing by enhancing lysosomal BACE1 degradation and reducing g-secretase activity due to shift from raft to non-raft fraction resulting in a bidirectional link between APP processing and sulfatides. Luminescence Assay:Article Title: A bidirectional link between sulfatide and Alzheimer's disease. Article Snippet: In brief Zimmer et al. report that the glycosphingolipid sulfatide is reduced in brains of Alzheimer’s patients.. AICD inhibits CST expression, necessary for sulfatide synthesis.. In return, sulfatides inhibit amyloidogenic APP processing by enhancing lysosomal BACE1 degradation and reducing g-secretase activity due to shift from raft to non-raft fraction resulting in a bidirectional link between APP processing and sulfatides. Bicinchoninic Acid Protein Assay:Article Title: A bidirectional link between sulfatide and Alzheimer's disease. Article Snippet: In brief Zimmer et al. report that the glycosphingolipid sulfatide is reduced in brains of Alzheimer’s patients.. AICD inhibits CST expression, necessary for sulfatide synthesis.. In return, sulfatides inhibit amyloidogenic APP processing by enhancing lysosomal BACE1 degradation and reducing g-secretase activity due to shift from raft to non-raft fraction resulting in a bidirectional link between APP processing and sulfatides. Enzyme-linked Immunosorbent Assay:Article Title: A bidirectional link between sulfatide and Alzheimer's disease. Article Snippet: In brief Zimmer et al. report that the glycosphingolipid sulfatide is reduced in brains of Alzheimer’s patients.. AICD inhibits CST expression, necessary for sulfatide synthesis.. In return, sulfatides inhibit amyloidogenic APP processing by enhancing lysosomal BACE1 degradation and reducing g-secretase activity due to shift from raft to non-raft fraction resulting in a bidirectional link between APP processing and sulfatides. Microscopy:Article Title: A bidirectional link between sulfatide and Alzheimer's disease. Article Snippet: In brief Zimmer et al. report that the glycosphingolipid sulfatide is reduced in brains of Alzheimer’s patients.. AICD inhibits CST expression, necessary for sulfatide synthesis.. In return, sulfatides inhibit amyloidogenic APP processing by enhancing lysosomal BACE1 degradation and reducing g-secretase activity due to shift from raft to non-raft fraction resulting in a bidirectional link between APP processing and sulfatides. |